PROgress Tracker ASCO 2026

Understanding the “Burden of Worry”: New insights from PROgress Tracker Breast Cancer Registry When someone finishes active breast cancer treatment, it’s often seen as the end of the medical journey. But for many survivors, that’s not how it feels. Even after surgery, chemotherapy, or radiation are over, many people continue to live with worry: about the cancer […]

BCC’s Survivorship Strategy

What Happens After the “All Clear”? Breast Cancer Canada Calls for Urgent Action to Support Canadian Breast Cancer Survivors As more younger Canadians are being diagnosed with breast cancer and survival rates continue to improve, Breast Cancer Canada (BCC) is calling on greater government investment to address an urgent, under-funded and critical gap in cancer […]

Survivorship at ASCO 2026

Beyond the Treatment Calendar: Reflecting on Breast Cancer The American Society of Clinical Oncology (ASCO) Annual Meeting is famously known as the place where ground-breaking clinical trials make their global debut. But beneath the headlines of percentages, survival curves, and molecule names, a vital shift is taking place. At ASCO 2026, held under the global […]

BCC at ASCO: Evolving Treatment Strategies in Metastatic Breast Cancer

mBC Treatment Discussions at ASCO 2026 One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was how treatment decisions are evolving for people living with metastatic breast cancer. Researchers are increasingly focused not only on which treatments work, but also on when they should be used. Advances […]

BCC at ASCO 2026: Early Breast Cancer 

One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was the continued shift toward personalized treatment for early breast cancer. Researchers presented new evidence demonstrating how genomic testing can help identify patients who may safely avoid chemotherapy, ensuring treatment decisions are guided by tumour biology rather than […]

Breast Cancer Canada Recommendations for the Federal Government

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget  Recommendation 1: That the Government of Canada, through the Public Health Agency of Canada, formally recognize and support implementation of Breast Cancer Canada and REAL Canadian Breast Cancer Alliance evidence-based standards of care as a national framework to promote equitable, timely, and […]

Remembering Dr. Juliet Daniel

Dr. Juliet Daniel’s passing from metastatic breast cancer is a profound loss to science, to McMaster University, to the Caribbean and Canadian communities that shaped her, and especially to the Black research community she helped make more visible, and connected. She leaves a legacy defined not only by discovery, but by courage: the courage to […]

Inaugural BCC–CSSO Career Development Research Award Presented to Dr. Matthew Castelo

Breast Cancer Canada (BCC) and the Canadian Society of Surgical Oncology (CSSO) are proud to announce the inaugural BCC-CSSO Career Development Research Award, a $200,000 investment aimed to build Canada’s breast surgical oncology research capacity and improve care delivery across the country. The inaugural recipient is Dr. Matthew Castelo. The award encourages partnership and co-investment […]

Meet the Researcher: Urvi Patel

Urvi Patel is a PhD student in the Department of Anatomy & Cell Biology at Western University. She is conducting BCC-funded breast cancer research under the mentorship of Dr. Alison Allan at the London Health Sciences Centre/Western University. My research focuses on how breast cancer spreads to the lungs, especially in triple negative breast cancer, […]

Sign Up, Know More